These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3492941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Levels of adenosine deaminase AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors.
    Fishbein WN, Davis JI, Winkert JW, Strong DM.
    Biochem Med; 1981 Dec; 26(3):377-86. PubMed ID: 6277304
    [No Abstract] [Full Text] [Related]

  • 3. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS, Danton MJ, Philips A.
    Ann N Y Acad Sci; 1985 Dec; 451():54-65. PubMed ID: 3878121
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
    Jackson RC, Leopold WR, Ross DA.
    Adv Enzyme Regul; 1986 Dec; 25():125-39. PubMed ID: 2433905
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F, Van den Berghe G.
    Cancer Res; 1989 Sep 15; 49(18):4983-9. PubMed ID: 2788493
    [Abstract] [Full Text] [Related]

  • 9. Adenosine and hypoxic vasodilatation.
    Dóra E.
    J Cereb Blood Flow Metab; 1985 Dec 15; 5(4):621-4. PubMed ID: 3877069
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Purification of adenosine deaminase from human red blood cells.
    Buel E, MacQuarrie R.
    Prep Biochem; 1981 Dec 15; 11(4):363-80. PubMed ID: 7312831
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
    Kefford RF, Fox RM.
    Cancer Chemother Pharmacol; 1983 Dec 15; 10(2):73-8. PubMed ID: 6600985
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human malaria parasite adenosine deaminase. Characterization in host enzyme-deficient erythrocyte culture.
    Daddona PE, Wiesmann WP, Lambros C, Kelley WN, Webster HK.
    J Biol Chem; 1984 Feb 10; 259(3):1472-5. PubMed ID: 6363411
    [Abstract] [Full Text] [Related]

  • 18. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD.
    Ann N Y Acad Sci; 1985 Feb 10; 451():188-203. PubMed ID: 3878117
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
    Franco R, Hoyle CH, Centelles JJ, Burnstock G.
    Gen Pharmacol; 1988 Feb 10; 19(5):679-81. PubMed ID: 3265122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.